SEVOFLURANE市場：按應用、分銷管道、地區、佔有率、前景和機會分析（2025-2032 年）

Sevoflurane Market, by Application, by Distribution Channel, and by Region Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，SEVOFLURANE市值將達到 4.203 億美元，到 2033 年將達到 5.836 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 4.8%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	4.203億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	4.80%	2033年市場規模預測：	5.836億美元

SEVOFLURANE是一種氣味香甜、不易燃、高度氟化的甲基異丙醚，用作吸入性麻醉劑，用於誘導和維持全身麻醉。它是DESFLURANE之後起效第二快的揮發性麻醉劑。

市場動態

市場參與者正致力於引入新技術，以支持透過吸入器麻醉劑，這有望在預測期內推動全球SEVOFLURANE市場的成長。例如，2022年4月，全球領先的醫療科技公司GE醫療宣布，吐氣末濃度（Et）控制軟體已獲得美國食品藥物管理局（FDA）的上市前批准（PMA）。在美國，GE醫療是唯一獲準提供吐氣末濃度控制全身麻醉的製造商。

預計需要麻醉的美容手術數量不斷增加將推動全球SEVOFLURANE市場的成長。例如，2022年4月，全球領先的臉部和身體美容整形外科及美容醫學專業學會－美國美容外科學會（The Aesthetic Society）發布了年度報告《美容整形外科統計》。該報告基於學會新推出的更精準的數位技術收集的數據，顯示2021年美國美容整形手術數量增加。數據顯示，臉部、胸部和身體相關手術的數量顯著增加。在美國，腹部整形、臀部整形和抽脂手術的受歡迎程度自2020年以來均增加了63%。隆乳、提胸和縮胸手術的數量也均增加了48%。

預計在預測期內，吸入麻醉劑回收技術的日益普及將推動市場成長。例如，2020年7月，全球領先的無菌藥品生產商和供應商百特國際公司宣布與醫療技術公司ZeoSys Medical達成正式協議，共同開發和商業化一種用於回收和循環利用麻醉氣體的技術。根據協議條款，百特將獲得該技術的全球分銷權、在歐洲以外地區獨家商業化該技術的許可，以及收購ZeoSys Medical的獨家選擇權。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、區域前景以及領先企業採取的競爭策略。
本研究根據以下參數對全球SEVOFLURANE市場的主要參與者進行了分析：公司概況、財務績效、產品系列、企業發展區域、分銷策略、關鍵發展和策略以及未來計劃。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
全球SEVOFLURANE市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球SEVOFLURANE市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第7章競爭情勢

公司簡介
- Abbott Laboratories
- Baxter
- Piramal Pharma Solutions
- Manus Aktteva Biopharma LLP
- Maruishi Pharmaceutical Co.,Ltd.
- Lunan Pharmaceutical Group
- Abbvie
- Wellona Pharma
- Rewine Pharmaceutical
- Troikaa Pharmaceuticals Limited

第8章分析師建議

機會分析
分析師意見
一致的機會地圖

第9章

參考
調查方法

簡介目錄

Product Code: CMI5031

Sevoflurane Market is estimated to be valued at USD 420.3 Mn in 2026 and is expected to reach USD 583.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 420.3 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.80%	2033 Value Projection:	USD 583.6 Mn

Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether that is used as an inhalational anesthetic for general anesthesia induction and maintenance. It is the fastest-acting volatile anesthetic after desflurane.

Market Dynamics

Market players are focused on launching new technology to help delivery of anesthesia through inhalers, this could contribute to the growth of the global sevoflurane market over the forecast period. For instance, in April 2022, GE Healthcare, a leading global medical technology company, announced that its end-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2 Anesthesia Delivery System has received pre-market approval (PMA) from the U.S. Food and Drug Administration (FDA). In the U.S., GE Healthcare is the only manufacturer approved to provide general anesthesia with end-tidal concentration control.

Increasing number of aesthetic surgeries requiring anesthesia, is expected to drive the growth of global sevoflurane market. For instance, in April 2022, The Aesthetic Society, world's leading association dedicated solely to facial and body aesthetic plastic surgery and cosmetic medicine issued its annual Aesthetic Plastic Surgery Statistics, which revealed that aesthetic plastic surgery increased in 2021 in U.S. owing to data acquired using the Society's new, more accurate digital technology. The data shows a large growth in procedures for the face, breasts, and body. Abdominoplasty, buttock augmentation, and liposuction have all seen a 63% surge in popularity since 2020 in U.S. Breast augmentation, augmentation/breast lift, and breast lift/reduction treatments all increased by 48%.

Increasing launches of technology to recycle inhaled anesthetics is expected to fuel the growth over forecast period. For instance, in July 2020, Baxter International Inc., a global leader in the production and delivery of sterile medications, announced a formal agreement with ZeoSys Medical, a medical technology company, to commercialize technology to capture and recycle anesthetic gases. Baxter will have worldwide distribution rights and an exclusive license to commercialize the technology outside of Europe, as well as an exclusive option to acquire ZeoSys Medical, under the terms of the agreement.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global sevoflurane market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Abbott Laboratories, Baxter, Piramal Pharma Solutions, Manus Aktteva Biopharma LLP, Maruishi Pharmaceutical Co.,Ltd., Lunan Pharmaceutical Group, Abbvie, Wellona Pharma, Rewine Pharmaceutical, and Troikaa Pharmaceuticals Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global sevoflurane market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global sevoflurane market.

Detailed Segmentation:

Global Sevoflurane Market, By Application (Revenue, USD Mn, 2021 - 2033)
Induction
Maintenance
Global Sevoflurane Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Sevoflurane Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- By Country:
  - U.S.
  - Canada
Latin America
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Country:
  - U.K.
  - Germany
  - Italy
  - Spain
  - France
  - Russia
  - Rest of Europe
Asia Pacific
- By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- By Country:
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Abbott Laboratories
Baxter
Piramal Pharma Solutions
Manus Aktteva Biopharma LLP
Maruishi Pharmaceutical Co.,Ltd.
Lunan Pharmaceutical Group
Abbvie
Wellona Pharma
Rewine Pharmaceutical
Troikaa Pharmaceuticals Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Porter's Analysis
Industry Trends
Key Highlights
Epidemiology
Reimbursement Scenario
Regulatory Scenario
Product Launch and Approvals
Acquisition and Collaboration Scenario

4. Global Sevoflurane Market, By Application, 2018-2031 (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2031 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2031, (US$ Million)
Maintenance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2031, (US$ Million)

5. Global Sevoflurane Market, By Distribution Channel, 2018-2031 (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2031 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2031, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2031, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2031, (US$ Million)

6. Global Sevoflurane Market, By Region, 2018-2031 (US$ Million)

Introduction
- Market Share Analysis, By Region, 2023 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
North America
- Market Size and Forecast, By Application, 2018-2031 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2018-2031 (US$ Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Application, 2018-2031 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2018-2031 (US$ Mn)
- Market Size and Forecast, By Country, 2018-2031 (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Application, 2018-2031 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2018-2031 (US$ Mn)
- Market Size and Forecast, By Country, 2018-2031 (US$ Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Application, 2018-2031 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2018-2031 (US$ Mn)
- Market Size and Forecast, By Country, 2018-2031 (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Application, 2018-2031 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2018-2031 (US$ Mn)
- Market Size and Forecast, By Country, 2018-2031 (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Application, 2018-2031 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2018-2031 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2018-2031 (US$ Mn)
  - South Africa
  - Central Africa
  - North Africa

7. Competitive Landscape

Company Profiles
- Abbott Laboratories*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Baxter
- Piramal Pharma Solutions
- Manus Aktteva Biopharma LLP
- Maruishi Pharmaceutical Co.,Ltd.
- Lunan Pharmaceutical Group
- Abbvie
- Wellona Pharma
- Rewine Pharmaceutical
- Troikaa Pharmaceuticals Limited